Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

Famciclovir (CAS 104227-87-4)

0.0(0)
Write a reviewAsk a question

Alternate Names:
2-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate ester
Application:
Famciclovir is a useful antiviral for biochemical research purposes
CAS Number:
104227-87-4
Purity:
≥98%
Molecular Weight:
321.34
Molecular Formula:
C14H19N5O4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Famciclovir is a synthetic guanine derivative used extensively in scientific research to understand the mechanisms of antiviral resistance and viral replication, particularly in relation to herpesviruses. It is metabolized in the body to produce penciclovir, which is the active compound that exhibits potent antiviral activity. The primary mechanism of action of famciclovir, through penciclovir, involves the inhibition of viral DNA polymerase. Penciclovir triphosphate, the active form, competes with deoxyguanosine triphosphate (dGTP) for incorporation into viral DNA. Once incorporated, it significantly slows down the rate of viral DNA synthesis, rather than causing immediate chain termination. This action allows researchers to study the kinetics and dynamics of viral DNA synthesis in a detailed manner. In research settings, famciclovir is used to model and study the replication of herpesviruses in cell cultures and animal models. Researchers use this compound to explore how herpesviruses replicate, adapt, and respond to antiviral agents. These studies are crucial for understanding the development of antiviral resistance and the ways in which viral DNA synthesis can be disrupted. Additionally, famciclovir is employed in studies focusing on the dynamics of viral infection, including latency and reactivation. By examining the effects of famciclovir on these processes, researchers gain insights into the life cycle of herpesviruses and potential strategies for managing viral dynamics.


Famciclovir (CAS 104227-87-4) References

  1. The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice.  |  LeBlanc, RA., et al. 1999. J Infect Dis. 180: 594-9. PMID: 10438344
  2. Effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice: how dissimilar are study results?  |  Thackray, AM. and Field, HJ. 2000. J Infect Dis. 181: 1517-8. PMID: 10762588
  3. Experimental studies on the antiviral agent famciclovir in Behçet's disease symptoms in ICR mice.  |  Sohn, S., et al. 2001. Br J Dermatol. 145: 799-804. PMID: 11736905
  4. The helicase primase inhibitor, BAY 57-1293 shows potent therapeutic antiviral activity superior to famciclovir in BALB/c mice infected with herpes simplex virus type 1.  |  Biswas, S., et al. 2007. Antiviral Res. 75: 30-5. PMID: 17175035
  5. Effects of antiviral medications on herpetic epithelial keratitis in mice.  |  Komoto, S., et al. 2015. Jpn J Ophthalmol. 59: 194-200. PMID: 25707352
  6. Effects of famciclovir in cats with spontaneous acute upper respiratory tract disease.  |  Kopecny, L., et al. 2020. J Feline Med Surg. 22: 492-499. PMID: 31246133
  7. Ginkgolic Acid Inhibits Herpes Simplex Virus Type 1 Skin Infection and Prevents Zosteriform Spread in Mice.  |  Bhutta, MS., et al. 2021. Viruses. 13: PMID: 33435520
  8. Antiviral activity of famciclovir and acyclovir in mice infected intraperitoneally with herpes simplex virus type 1 SC16.  |  Ashton, RJ., et al. 1994. J Antimicrob Chemother. 34: 287-90. PMID: 7814291
  9. Famciclovir and valaciclovir differ in the prevention of herpes simplex virus type 1 latency in mice: a quantitative study.  |  Thackray, AM. and Field, HJ. 1998. Antimicrob Agents Chemother. 42: 1555-62. PMID: 9660982

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Famciclovir, 100 mg

sc-211498
100 mg
$123.00